Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

103.97 +0.28 (+0.27%)

Streaming Delayed Price Updated: 2:35 PM EDT, Sep 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

52 53 Next >

Is the Market Bullish or Bearish on Abbott Laboratories? ↗

October 28, 2025

Via Benzinga

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? ↗

October 28, 2025

Englander seems to have had several good reasons to aggressively buy shares of this big drugmaker.

Via The Motley Fool

Topics Intellectual Property

Abbott Laboratories (NYSE:ABT): A Strong Dividend Stock for Reliable Income and Growth ↗

October 27, 2025

Discover Abbott Laboratories (ABT), a top dividend stock with a 1.87% yield, 11% growth, and a strong financial profile for reliable income.

Via Chartmill

Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence

October 23, 2025

New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares...

Via MarketMinute

Topics Earnings Supply Chain

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards ↗

October 23, 2025

Trinity Capital Inc. announced a financing agreement with Bobbie, an organic infant nutrition company, to boost production capacity and ensure wider distribution of its products.

Via Benzinga

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question

October 23, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

October 22, 2025

Via Benzinga

Boston Scientific Soars: Q3 2025 Earnings Beat Ignites Medical Device Market

October 22, 2025

Boston Scientific (NYSE: BSX) has delivered an exceptional third-quarter 2025 earnings report, significantly surpassing analyst expectations and reinforcing its position as a leading innovator in the...

Via MarketMinute

Topics Artificial Intelligence Earnings Economy

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call

October 22, 2025

Abbott Laboratories’ third quarter results met Wall Street’s expectations for both revenue and non-GAAP profit, but the market reacted negatively, with shares declining over 4%. Management pointed to...

Via StockStory

Topics Earnings

U.S. Job Growth Stalls at 0.1%: Echoes of 2009 as Economy Navigates Fragile Labor Market

October 21, 2025

The U.S. economy is currently grappling with a significant deceleration in job growth, with proprietary data from investment giant Vanguard revealing a meager 0.1% growth rate for seven of the first...

Via MarketMinute

Topics Artificial Intelligence Economy Immigration

Abbott Laboratories' October Price Plunge Is a Signal to Buy ↗

October 17, 2025

Abbott Laboratories is on track to reach new highs, potentially by early 2026, opening the door for a 30% stock price increase in addition to the dividend.

Via MarketBeat

Earnings Season Fuels Market Optimism Amidst Economic Headwinds

October 16, 2025

As the Q3 2025 earnings season unfolds, corporate America is delivering a powerful narrative of resilience and growth, significantly influencing overall stock market movements. Despite a complex...

Via MarketMinute

Topics Artificial Intelligence Economy Workforce

Analyst See Noise In Q3 P&L, Affirms Abbott's Medtech Strength ↗

October 16, 2025

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global expansion.

Via Benzinga

These Analysts Revise Their Forecasts On Abbott Following Q3 Results ↗

October 16, 2025

Via Benzinga

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever. ↗

October 16, 2025

Investors should be able to count on these stocks to deliver steady and growing income over the long term.

Via The Motley Fool

ABT Q3 Deep Dive: Q3 Results in Line with Expectations, Product Pipeline and Market Dynamics Shape Outlook

October 16, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30...

Via StockStory

Topics World Trade

U.S. Stocks End Mixed Amidst Trade Tensions, Dovish Fed Hopes, and Robust Earnings

October 15, 2025

The U.S. stock market closed with a mixed performance recently, reflecting a complex and dynamic environment where investor sentiment is being pulled in multiple directions. As of October 15, 2025, a...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Why Abbott Laboratories (ABT) Stock Is Down Today

October 15, 2025

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 3.5% in the afternoon session after the company reported third-quarter financial results that met, but did not...

Via StockStory

Gold Gains Over 1%; Abbott Shares Fall After Q3 Results ↗

October 15, 2025

Via Benzinga

Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025

October 15, 2025

In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Bank Earnings Lift Wall Street, Gold Hits $4,200: What's Moving Markets Wednesday? ↗

October 15, 2025

Wall Street rose on Wednesday, with investor optimism lifted by strong bank and corporate earnings alongside growing expectations for further Federal Reserve rate cuts — keeping trade concerns...

Via Benzinga

Topics Economy

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 15, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows ↗

October 15, 2025

Via The Motley Fool

Topics Regulatory Compliance

These S&P500 stocks are gapping in today's session ↗

October 15, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.

Via Chartmill

1 No-Brainer Dividend Stock to Buy and Hold Forever ↗

October 15, 2025

This is about as safe as a dividend can be.

Via The Motley Fool

Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations ↗

October 15, 2025

Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices.

Via Benzinga

Topics Earnings

Abbott Labs Skids On Mixed Third-Quarter Report, But One Segment Shined ↗

October 15, 2025

Notably, the company reaffirmed its sales guidance and the midpoint of its earnings outlook.

Via Investor's Business Daily

What's going on in today's pre-market session: S&P500 movers ↗

October 15, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

Abbott Laboratories (NYSE:ABT) Trims 2025 Outlook After Q3 Earnings ↗

October 15, 2025

Abbott Labs Q3 2025 results met EPS views, but trimmed full-year guidance. Sales grew 6.9% as the healthcare giant navigates a complex market.

Via Chartmill

Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations

October 15, 2025

Via StockStory

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

Headline News about Abbott Laboratories

Starting at /week.